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Background: The burden of cardiovascular disease (CVD) prompted the American Heart Association to 
develop a cardiovascular health (CVH) metric as a measure to assess the cardiovascular status of the 
population. We aimed to assess the association between CVH scores and the risk of CVD mortality 
among a middle-aged Finnish population.  
Methods: We employed the prospective population-based Kuopio Ischemic Heart Disease cohort study 
comprising of middle-aged men (42 to 60 years). CVH scores were computed among 2,607 participants at 
baseline and categorized as optimum (0-4), average (5-9), or inadequate (10-14) CVH. Multivariate cox 
regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) of 
CVH score for cardiovascular mortality.  
Results: During a median follow-up period of 25.8 years, 609 CVD mortality cases were recorded. The 
risk of CVD mortality increased gradually with increasing CVH score across the range 3-14 (p-value for 
non-linearity=0.77). Men with optimum CVH score had HR (95% CI) for CVD mortality of 0.30 (CI 0.21 
– 0.42, p<0.0001) compared to those with inadequate CVH score after adjustment for conventional 
cardiovascular risk factors.   
Conclusions: CVH score was strongly and continuously associated with the risk of CVD mortality 





Cardiovascular disease (CVD) remains a global health burden and ranks among the top leading 
causes of mortality worldwide (1). Lifestyle factors, among other modifiable risk factors, have contributed 
significantly to CVD(2). Healthy diet, regular physical activity and smoking cessation have been reported 
to reduce mortality by 15- 40%, 20-30% and 50% respectively (3). However, as the prevalence of certain 
life-style related cardiovascular risk factors increases, e.g. diabetes and overweight or obesity, measures 
for CVD prevention remain crucial (4,5). There are attempts to combine information on many CVD risk 
factors to show the importance of the metrics generated when maintained at optimal level, in relation to 
CVD mortality. 
In 2010, the American Heart Association (AHA) proposed and developed a new metric for ideal 
cardiovascular health (CVH) as a means to assess the cardiovascular status of the population. This metric 
focused on 7 cardiovascular-risk modifiable health behaviors and biological factors, comprising of 
smoking, body mass index (BMI), physical activity, fasting blood glucose, total cholesterol, blood 
pressure and diet. This was part of AHA’s established goal to reduce mortality from CVD and stroke, 
while improving the cardiovascular health of the American population by 20% by 2020 (6). Studies have 
shown inverse associations between CVH status and risk of CVD in both subclinical and clinical settings 
(7-14).  
In Finland, CVD contributes to about 40% of total mortality across all ages and sex (15). Thus, 
assessing measures of CVD and their risk for CVD need to be explored and adopted in this population. 
Studying the applicability of the AHA’s CVH metrics approach may be paramount towards determining 
effective approaches to reduce CVD mortality among the Finnish population. To the best of our 
knowledge, the association between CVH metrics and risk of CVD mortality has not yet been assessed in 
the Finnish population. A recent meta-analysis further substantiated this, showing no prospective study 
has been done to demonstrate any association between ideal CVH metrics and cardiovascular mortality in 




defined by AHA) and the risk of CVD mortality among a middle-aged Finnish population, and to evaluate 
the applicability of AHA’s CVH score in this population. 
2. Materials and Methods 
2.1. Study population 
This study employed the ongoing prospective population-based Kuopio Ischemic Heart Disease 
(KIHD) cohort study. The KIHD was designed to investigate the different risk factors for developing 
CVD and other chronic diseases among middle-aged and aging men and women in Kuopio and the 
surrounding communities in Eastern Finland (17,18). Briefly, the study commenced in 1984 with a 
baseline sample of 3433 men aged 42 to 60 years, who were randomly selected from the national 
population register, out of which 3235 were found to be eligible. At baseline examination between March 
1984 and December 1989, 2682 men (82.9% of those eligible) volunteered to participate in this study, 
186 did not respond to the invitation and 367 declined to give informed consent. The present analysis is 
based on 2607 men with non-missing data on CVH metrics, relevant co-variates, and CVD mortality. The 
research protocol (KIHD) was approved by the Research Ethics Committee of the University of Eastern 
Finland, Kuopio with reference number 143/97. The study protocol conforms to the ethical guidelines of 
the Declaration of Helsinki. Informed consent was obtained from all individual participants included in 
the study. 
2.2. Data collection 
A self-administered questionnaire was mailed to each participant prior to their visit to the study 
centre. The participants were then invited to the study centre for interviews and clinical examination. A 
trained research nurse was responsible for interviewing all the study participants, who also went through a 
health examination. Nutritional assessment was done using a 4-day food record diary. Information 
concerning education, type of occupation, smoking status and duration of regular smoking in years, 
alcohol consumption, and past medical condition was obtained using detailed questionnaires and were 
checked during medical examination by a physician. Additionally, physical examination including height, 




in kilograms divided by height in meters squared (kg/m2). Resting blood pressure was measured with a 
random-zero sphygmomanometer (Hawskley, UK) between 8 and 10 am after 5 and 10 minutes of rest in 
a seated position (19). The physical activity was measured using questionnaires involving a 12-month 
leisure activity history (modified from the Minnesota leisure time activity questionnaire), a 7-day leisure 
time activity recall, the 24-hour total activity recording and the occupational activity interview. All 
metabolic indices were calculated using the product of duration of each activity and the caloric coefficient 
of the specific activity and intensity class. The intensity was expressed in metabolic units (MET), which is 
the ratio of metabolic rate during activity to the metabolic rate at rest (20). Adulthood socioeconomic 
status (SES) was assessed as a combined measure of income, education, occupation, occupational 
prestige, material standard of living, and housing conditions. The SES scale ranges from 0 through 25; 0 
indicating the highest, and 25 the lowest SES. 
2.3. Laboratory methods 
Participants provided blood specimens between the hours of 8 and 10 in the morning after having 
abstained from alcohol ingestion for 3 days, smoking for 12 hours and eating for 12 hours. After the 
subject had rested for 30 minutes in the supine position, blood sample was drawn from the antecubital 
vein with Terumo Venoject VT-100PZ vacuum (Terumo Corp., Tokyo), without the use of tourniquet. 
The cholesterol contents of serum lipoprotein fractions and triglycerides were measured enzymatically 
(Boehringer Mannheim). Serum high-density lipoprotein cholesterol (HDL-C) and its subfractions were 
separated from fresh serum samples using ultracentrifugation and precipitation. Blood glucose was 
measured by glucose dehydrogenase method (Merck, Darmstadt, FRG) after precipitation of proteins by 
trichloric acetic acid.(19). 
2.4. Assessment of Cardiovascular Health Metrics 
The CVH metrics adopted in this study was in conformity with the newly developed CVH 
metrics of the AHA, consisting of seven health behaviors and factors including healthy diet score (HDS), 




level of each CVH metric was classified at baseline as ideal, intermediate, or poor (Table 2). 1) Healthy 
diet score: The AHA has considered an ‘ideal’ adult diet as the consumption of four or five of the 
following: at least 4.5 cups per day of fruits and vegetables, at least two 3.5-ounce servings a week of fish 
(oily is best), less than 1,500 milligrams a day of sodium, fewer than 450 calories (36 ounces) a week of 
sweets/sugar and at least three 1-ounce servings a day of whole grains. Additional three factors, 
considered as secondary dietary metrics, are also considered to contribute to a healthy diet. These are: less 
than 7% of total calories from saturated fat, at least 4 servings a week of nuts, legumes or seeds and none 
or fewer than 2 servings a week of processed meats (6).  
Based on the available data in KIHD study, the salt intake for the calculation of the HDS was 
substituted with the intake of processed meat, which has been shown to contain much salt (sodium) (21). 
Therefore, HDS among participants with 4 to 5 components was considered ‘ideal’; 2 to 3 components 
considered ‘intermediate’ diet; and 0 to 1 as ‘poor’ adult diet. 2) Blood pressure: Ideal BP was defined as 
systolic BP <120mmHg and diastolic BP <80mmHg. Intermediate BP was considered as having systolic 
BP of 120mmHg – 139mmHg or diastolic BP of 80mmHg – 89mmHg. Poor BP was defined as a systolic 
BP ≥ 140mmHg or diastolic BP ≥ 90mmHg. 3) Physical activity: Participants were considered to have 
ideal physical activity when they pursue at least 150 minutes per week of moderate-intensity physical 
activity (MET 3-6) or 75 minutes per week of vigorous intensity aerobic physical activity (MET >6), or 
an equivalent combination of moderate- and vigorous-intensity aerobic activities. Intermediate physical 
activity was considered as having 1 – 149 minutes per week of moderate intensity physical activity (MET 
3-6) or 1 -74 minutes per week of vigorous intensity aerobic physical activity, or an equivalent 
combination of both. Poor physical activity was defined as no physical activity. 4) Body mass index: 
Ideal, intermediate and poor BMI were defined as <25 kg/m2, 25 – 29 kg/m2 and ≥ 30 kg/m2 respectively. 
5) Smoking status: Ideal smoking status was defined as men who never smoked, whereas previous and 
current smokers were considered as having intermediate and poor smoking status respectively. 6) Total 




was 5.18 -6.21 mmol/l (200 – 240 mg/dl), and ≥ 6.22mmol/l (240 mg/dl) was considered poor total 
cholesterol level. 7) Blood glucose: Fasting blood glucose <5.55 mmol/l (100 mg/dl) was considered as 
ideal, 5.55 – 6.99 mmol/l (100 – 125mg/dl) considered as intermediate, and ≥7.00 mmol/l (126 mg/dl) 
considered as poor. 
The participants were assigned a score of 0 if they met the ideal level, with 1 and 2 for 
intermediate and poor levels respectively, based on the seven CVH metrics. In total, the metric scores for 
each subject ranged from 0 to 14, with lower scores representing a better CVH score. These scores were 
thus classified as optimum (0-4), average (5-9), or inadequate (10-14) CVH. 
2.5. Cardiovascular disease mortality surveillance 
All deaths that occurred from study enrolment to the end of 2014 were checked against the 
hospital documents, health center wards, and death certificates. The sources of information were 
interviews, hospital documents, death certificates, autopsy reports, and medicolegal reports. All CVD 
deaths were ascertained by a computer linkage to the national death registry using the Finnish personal 
identification code (social security number), therefore no losses to follow-up was recorded in this study. 
CVD deaths were coded using International Classification of Diseases, Ninth Revision (ICD-9), and 
International Statistical Classification of Diseases, 10th Revision (ICD-10) codes. The documents related 
to the death were cross-checked in detail by 2 physicians. The Independent Events Committee, masked to 
clinical data, performed classification of deaths(22) . 
2.6.  Statistical analysis 
Descriptive statistics were used to summarize the baseline characteristics of the participants.  
Baseline characteristics were presented as means (standard deviation, SD) or median (interquartile range, 
IQR) for continuous variables and number and percentages for categorical variables. To assess differences 
in baseline characteristics, we used analysis of variance for continuous variables and chi-squared tests for 
categorical variables. Multivariate cox regression models were used to estimate the hazard ratios (HRs) 




major departure from the proportionality assumptions using Schoenfeld residuals (23). CVH score was 
modelled based on the following categories: optimum; average; and inadequate, with inadequate CVH 
used as the reference comparison. We explored the shape of any dose-response relationship between CVH 
score (as a continuous variable) and CVD mortality, using restricted cubic spline with knots at the 5th, 
35th, 65th and 95th percentiles of the distribution of CVH score in a multivariate adjusted model.  
Hazard ratios were calculated with adjustment for confounders in two models: i) age, alcohol 
consumption and SES; (ii) plus HDL-C, use of cholesterol lowering medications, use of 
antihypertensives, history of CHD and history of type 2 diabetes mellitus. These covariates were selected 
based on previously established roles as risk factors and their potential as confounders as a result of their 
known associations with cardiovascular mortality and also taking into consideration factors used in 
derivation of the CVH score. All statistical analyses were conducted using Microsoft windows software, 
IBM SPSS Statistics 25 (SPSS Inc., Chicago, IL, USA 9). Two-sided p-value <0.05 was considered 
statistically significant. 
3. Results 
The baseline characteristics of the participants are shown in Table 1. The mean age (SD) of the 
study population was 53.1 (5.1) years. The number of participants (%) in the different categories of the 
CVH score were as follows: inadequate, 362 (13.9); average, 1879 (72.1); and optimum, 366 (14.0). 
Among these participants, 658 (25.2 %) of them had history of CHD at baseline. During the median 
follow-up years of 25.8 [IQR 18.4 – 27.9] years, 609 cases of CVD mortality occurred. Among CVD 
deaths recorded, 44 (7.2%), 435 (71%) and 130 (21.3%) had optimum, average and inadequate CVH 
scores respectively. The years from baseline to CVD deaths between the groups of CVH score, 
inadequate, average and optimum, are 15, 17 and 17.6 respectively (Supplementary Table).  
The distribution of the CVH metrics among the KIHD study participants showed variations in the 
individual components and in the number of the ideal CVH metrics (Table 2). For the CVH behaviors, 
77.9% of the participants attained the ideal physical activity level, 31.3% had ideal BMI, 32.2% never 




participants had ideal blood pressure, 39% had ideal fasting blood glucose and 25.7% had ideal total 
cholesterol. However, only one participant achieved all the seven ideal CVH metrics. 
A restricted cubic spline curve showed that the risk of CVD mortality increased gradually with 
increasing CVH score across the range 3-14 (p-value for non-linearity=0.774) (Figure 1). Table 3 shows 
the association between CVH score and risk of CVD mortality. In analysis that adjusted for age, alcohol 
consumption and socioeconomic status, men who had an optimum CVH score had a 70% reduced risk of 
CVD mortality when compared with those who had an inadequate CVH score (HR: 0.30; 95%CI: 0.21-
0.42, p <0.0001). After further adjustment HDL-C, use of cholesterol lowering medication, use of 
antihypertensive medications, history of CHD and history of type 2 diabetes mellitus, (model 2), the 
association was minimally attenuated (HR: 0.35; 95%CI: 0.24 – 0.49, p <0.0001). In subsidiary analysis 
that excluded men with any history of CVD at baseline, the respective association remained consistent 
(HR: 0.35; 95%CI: 0.21 – 0.59, p <0.0001).  
 
4. Discussion 
Using the AHA CVH metrics, we have assessed the association between CVH score and risk of 
CVD mortality among an apparently healthy Scandinavian population. The study showed that men with 
an optimum or average CVH score had substantially lower risk of CVD mortality when compared with 
men with inadequate CVH score. The associations were independent of several established risk factors. 
Additionally, this finding remained persistent after the exclusion of men with any history of CVD at 
baseline. A dose-response analysis showed that the risk of CVD mortality increased gradually with 
increasing CVH score across the range 3-14. 
Our recent findings are consistent with earlier studies conducted in other populations. In the 
Northern Manhattan Study, the relationship between the number of ideal CVH metrics and the risk of 
CVD was studied. The study revealed that there was a 59% lower risk of CVD events and 41 % lower 
risk of all-cause mortality among participants with 5-7 ideal CVH metrics, when compared with those 




Nutrition Examination Survey, where participants who had at least five ideal CVH metrics had reduced 
mortality from diseases of the circulatory system when compared to those who had no ideal health metric. 
Also, the risk for mortality from CVD was decreased by 88%, when comparing participants with 
minimum of 5 to those with no ideal CVH metrics (12). The Framingham Offspring Study reported a 
similar result, showing a unit increase in CVH score was associated with a 13% reduced risk of CVD.  
Each participant had the CVH score constructed by recoding the 7 metrics, with a score of 1 indicating 
the ideal category for AHA metrics (versus 0 for nonideal metric); thus, the CVH score varied from a 
minimum of 0 (indicating poor CVH) to a maximum of 7 (reflecting ideal cardiovascular health) (7). This 
was reverse of the coding of the CVH score in this current study (where 0 was ideal, 1 for intermediate 
and 2 for poor levels), nevertheless the results were similar. Among the Chinese population, Zhou and 
colleagues found an inverse association between ideal CVH metrics and risk of many cardiovascular 
endpoints including total CVD events and deaths from all cause and CVD (24). Similar findings were 
observed in the Kailuan Study, where a strong inverse relationship between ideal CVH metrics and risk of 
CVD was reported, with participants having 6-7 ideal CVH metrics had 82% lower risk for CVD events 
when compared to those with 0 ideal CVH metrics (25,26). 
This study provides further insight on the prevalence of AHA CVH metrics among middle-aged 
men living in Eastern Finland. The distribution of the individual components of the metrics shows that 
most men attained the ideal physical activity according to AHA CVH metrics. However, ideal HDS was 
the least achieved among this KIHD study population. Similar findings have been reported in the United 
States. For instance, in the Aerobics Center Longitudinal Study (ACLS) cohort (27), and the Mediators of 
Atherosclerosis in South Asians Living in America (MASALA) study participants, where more than half 
of the participants had ideal physical activity while very few achieved the ideal HDS or quality diet (28)  
Several studies have reported independent associations of individual risk factors such as physical 
inactivity, unhealthy diet, smoking, high blood pressure, overweight or obesity and the risk of CVD 




on CVD mortality. For instance, in the current study, 77.9% of the participants maintained ideal physical 
activity level, whereas in the same population group, only 1.9% attained the ideal HDS. If physical 
activity is isolated as an approach to reduce CVD mortality among this population group, it may not 
achieve the set goal in the prevention of CVD mortality, if healthy diet is not considered and improved. 
Optimum CVH score compared to inadequate CVH score is strongly associated with reduced risk of CVD 
mortality among the Scandinavian population. Therefore, AHA CVH metrics is a welcome approach for 
public health awareness and to monitor the cardiovascular health among Scandinavian population. 
However, future study is needed to investigate how CVH score can also be applied in Scandinavian 
women for the risk of CVD mortality. 
4.1. Study limitations 
There were some limitations in this study. First, the result cannot be generalized among the entire 
Scandinavian population, since it did not include women and other ethnicities. Second, the substitution of 
the salt intake in the AHA-definition with the intake of processed meat might have some effect in the 
computation of the HDS used in this study. Also, given the long period of follow-up, it is likely that the 
levels of CVH metrics may change over time, leading to the underestimation of true associations. 
Nevertheless, the strength of the study lies in the relatively large number of participants, being a 
representative sample of middle-aged male population in Eastern Finland. They were well characterized 
and followed-up during the study period with well-documented data.  
5. Conclusion 
CVH score was strongly and continuously associated with the risk of CVD mortality among a 
middle-aged Finnish population and this was independent of other conventional risk factors. This shows 
the value of coexistent effects of risk factor combinations on the risk of fatal CVD events in a male 
population. 
Key messages: 




Adopting the American Heart Association’s cardiovascular health metrics is a welcome approach for 
public health awareness and monitoring of cardiovascular health among Scandinavian population. 
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Table 1: Baseline characteristics and outcomes of the participants 




Cardiovascular disease death 
(n= 609) 
Alive individuals at the end of 
follow-up period (n= 1998) 
Age (years) 53.1 (5.1) 54.7 (4.2) 52.6 (5.3) 
High density cholesterol 
(mmol/l)a 
1.3 (0.3) 1.3 (0.3) 1.3 (0.3) 
Socioeconomic status 12.3 (5.1) 13.4 (5.0) 11.9 (5.1) 
Alcohol/week (g) 31.5 (6.2 - 92.1) 34.1 (5.4 – 111.6) 30.5 (6.3 – 88.2) 
History of coronary heart 
disease b 
658 (25.2) 246 (40.4) 412 (20.6) 
History of type 2 diabetes 
mellitus b 
157 (6.0) 72 (11.8) 85 (4.3) 
Antihypertensive 
medicationsb 
583 (22.4) 204 (33.5) 379 (19.0) 
Cholesterol lowering 
medications b 
17 (0.7) 4 (0.7) 13 (0.7) 
Cardiovascular health score b 
     Inadequate 
     Average 













a mmol/l x 38.6= mg/dl; bValues are in numbers (%); g, gram; mmol/l, millimole per litre 
Socioeconomic status (SES) was defined, on a scale of 0 to 25, as a combined measure of income, education, 
occupation, occupational prestige, material standard of living and housing conditions with 0 being highest SES, and 





Table 2: Distribution of cardiovascular health metrics among participants and based on cardiovascular 
mortality  
Cardiovascular Health Metrics All participantsa 
(n=2607) 
Cardiovascular Disease 
Deatha  (n=609) 
Alive individuals at the 
end of follow-up perioda 
(n=1998) 
Physical Activity  
Ideal (150mins/week of moderate-intensity or 75mins/week of 
vigorous intensity or both) 
Intermediate (1-149 mins/week of moderate intensity physical 
activity or 1-74 mins/week of vigorous intensity or both) 



















Body Mass Index 
Ideal (<25 kg/m2) 
Intermediate (25 – 29 kg/m2) 













Healthy Diet Scoreb 
Ideal (4 - 5) 
Intermediate (2 – 3) 













Blood Pressure (mmHg) 
Ideal (SBP <120 and DBP <80) 
Intermediate (SBP, 120 – 139 or DBP, 80 – 89) 













Fasting Blood Glucose (mmol/l)c 
Ideal (<5.55) 

















Total Cholesterol (mmol/l)d 
Ideal (< 5.18) 
Intermediate (5.18 -6.21) 














Ideal (never smoked) 
Intermediate (previous smokers) 


















































a Values presented as number (%); b1% missing; c mmol/l x 18 = mg/dl; d mmol/l x 38.6= mg/dl 






Table 3. Associations between cardiovascular health score and risk of cardiovascular mortality 
 
HR, hazard ratio 
The hazard ratios compared ‘optimum’ and ‘average’ cardiovascular health with ‘inadequate’ cardiovascular health. 
Model 1, Adjusted for age; alcohol consumption; socioeconomic status 
Model 2, Model 1 plus high-density lipoprotein cholesterol; use of cholesterol lowering medications, use of 
antihypertensives, history of coronary heart disease and history of type 2 diabetes mellitus. 
  
Cardiovascular 
health metrics score 
Number of 
events/Total 
Model 1  Model 2  











0.57 (0.47 – 0.70) 







0.64 (0.52 - 0.78) 








Supplement Table. Baseline characteristics of the study participants according to cardiovascular health score 
SD, standard deviation; IQR, interquartile range; mmol/l- millimole per litre; g, gram; CHD, coronary heart disease;  
*Statistical significance for categorical variables tested using chi-squared method, and analysis of variance 
procedure for continuous variables. 
Socioeconomic status was defined as a combined measure of income, education, occupation, occupational prestige, 
material standard of living and housing conditions. 
  
Characteristics (mean [SD] or 
median [IQR]) 
Optimum (0-4) Average (5-9) Inadequate 
(10-14) 
P-value * 
N 366 1879 362  
Age (years) 52.5 (5.5) 53.2 (5.2) 53.3 (4.6) 0.05 
High-density lipoprotein cholesterol 
(mmol/l) 
1.3 (0.3) 1.3 (0.3) 1.2 (0.3) <0.0001 
Socioeconomic status 10.4 (5.2) 12.4 (5.1) 13.8 (4.6) <0.0001 
Alcohol consumption/ week (g)  15.0 (49) 32.0 (88) 46.8 (131) <0.0001 
     
Number (%) of participants 
History of CHD 71 (19.4) 469 (25.0) 118 (32.6) <0.0001 
History of type 2 diabetes mellitus 13 (3.6) 113 (6.0) 31 (8.6) 0.02 
Antihypertensive medications 77 (21.0) 409 (21.8) 97 (26.8) 0.09 





Figure 1. Dose-response curve of hazard ratio for cardiovascular disease mortality against cardiovascular health 
score. 
Restricted cubic spline functions were analysed with knots located at 5th, 35th, 65th and 95th percentiles of 
cardiovascular health score distribution, with the reference category set at 3; adjusted for age; alcohol consumption; 
socioeconomic status; high-density lipoprotein cholesterol; use of cholesterol lowering medications, use of 
antihypertensives, history of coronary heart disease and history of type 2 diabetes mellitus. The dashed lines 
represent the 95% confidence intervals. 









Supplement Figure. Survival Plot showing the association between cardiovascular health score and cardiovascular 
death 
 
 
 
